Miles Maxwell - Concepedia

Author

Miles Maxwell

Also Known As

M MAXWELL, M. MAXWELL, M. Maxwell, M. P. Maxwell, M.P. Maxwell, MAXWELL, M, Miles Maxwell, Miles P Maxwell, Miles P. Maxwell

Publications

325

Citations

H-Index

Concepts

All Affiliations

St Thomas' Hospital Institute of Medicinal Plant Development

About

Miles Maxwell is an author at St Thomas' Hospital specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	208
2	Biochemistry	3	3	52
3	Natural Sciences	2	2	27
4	Public Health	1	1	56
5	Chemical Biology	1	1	16

Miles Maxwell

Publications

284

Citations

H-Index

Page 1

	Year	Citations
Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: Verapamil infusion in dogs with small myocardial infarcts Derek M. Yellon, David J. Hearse, Miles Maxwell, The American Journal of Cardiology Myocardial Necrosis 24Cardiovascular DiseaseMyocardial InfarctionAcute Myocardial InfarctionCoronary Artery Occlusion	1983	56
The Time Course of Cardioprotection Induced by GR79236, a Selective Adenosine A1-Receptor Agonist, in Myocardial Ischaemia-Reperfusion Injury in the Pig James B. Louttit, A. A. E. Hunt, Miles Maxwell, Journal of Cardiovascular Pharmacology Heart FailureCardiovascular PharmacologyPharmacotherapyMyocardial Ischaemia-reperfusion InjuryAtherosclerosis	1999	54
Synthesis and Serotonergic Activity of Substituted 2,<i>N</i>-Benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-<i>N</i>,<i>N</i>-dimethyltrypt- amine Derivatives: Novel Antagonists for the Vascular 5-HT<sub>1B</sub>-like Receptor Gerard P. Moloney, Graeme R. Martin, Neil Mathews, Journal of Medicinal Chemistry	1999	43
Particle-induced coronary vasoconstriction during cardioplegic infusion David J. Hearse, Çetin Erol, Lary A. Robinson, Journal of Thoracic and Cardiovascular Surgery Cardiogenic ShockCardiovascular DiseasePhysiologyCardiovascular PhysiologyMedicine	1985	36
Discovery and characterization of GSK256073, a non-flushing hydroxy-carboxylic acid receptor 2 (HCA2) agonist Dennis L. Sprecher, Miles Maxwell, Joanne Goodman, European Journal of Pharmacology Molecular PharmacologySignal TransductionBiochemistryG Protein-coupled ReceptorMedicine	2015	25
Inability of Desferrioxamine to Limit Tissue Injury in the Ischaemic and Reperfused Rabbit Heart Miles Maxwell, David J. Hearse, Derek M. Yellon Journal of Cardiovascular Pharmacology	1989	20
Synthesis and serotonergic activity of 2-oxadiazolyl-5-substituted-N,N-dimethyltryptamines: novel antagonists for the vascular 5-HT1B-like receptor Gerard P. Moloney, Graeme R. Martin, Neil Mathews, Journal of the Chemical Society Perkin Transactions 1 Fold Selectivity5-Ht1b-like ReceptorPharmacotherapyChemical BiologyExperimental Pharmacology	1999	16
Inability of Metoprolol to Achieve a Sustained Limitation of Infarct Size 24 h After Coronary Artery Embolization in the Closed Chest Dog Yasuo Kudoh, Miles Maxwell, David J. Hearse, Journal of Cardiovascular Pharmacology	1984	13
Synthesis and serotonergic activity of a series of 2-(N-benzyl)carboxamido-5-substituted-N,N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT1B-like receptors Gerard P. Moloney, Graeme R. Martin, Neil Mathews, Journal of the Chemical Society Perkin Transactions 1 Organic ChemistryPharmacotherapyHeterocycle ChemistryPharmaceutical ChemistryMedicinal Chemistry	1999	11
Inability of Metoprolol to Achieve a Sustained Limitation of Infarct Size 24 h After Coronary Artery Embolization in the Closed Chest Dog Yasuo Kudoh, Miles Maxwell, David J. Hearse, Journal of Cardiovascular Pharmacology Cardiovascular PharmacologyPharmacotherapySustained LimitationAcute Myocardial InfarctionThrombosis	1984	10

Page 1